Sagimet Biosciences (SGMT) Total Liabilities: 2023-2024
Historic Total Liabilities for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to $4.1 million.
- Sagimet Biosciences' Total Liabilities fell 18.97% to $4.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.1 million, marking a year-over-year decrease of 18.97%. This contributed to the annual value of $5.7 million for FY2023, which is N/A change from last year.
- Latest data reveals that Sagimet Biosciences reported Total Liabilities of $4.1 million as of Q3 2024, which was down 28.56% from $5.7 million recorded in Q2 2024.
- Sagimet Biosciences' Total Liabilities' 5-year high stood at $5.7 million during Q2 2024, with a 5-year trough of $4.1 million in Q3 2024.
- Its 2-year average for Total Liabilities is $5.1 million, with a median of $5.2 million in 2023.
- The largest annual percentage gain for Sagimet Biosciences' Total Liabilities in the last 5 years was 8.24% (2024), contrasted with its biggest fall of 18.97% (2024).
- Sagimet Biosciences' Total Liabilities (Quarterly) stood at $5.7 million in 2023, then decreased by 18.97% to $4.1 million in 2024.
- Its last three reported values are $4.1 million in Q3 2024, $5.7 million for Q2 2024, and $4.5 million during Q1 2024.